These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6046511)

  • 1. Proprietary drugs vs. generic drugs.
    Deichmann WB
    GP; 1967 May; 35(5):173-6. PubMed ID: 6046511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical economics and socialistic organization. 19. Needs and demands of the drug internal market].
    Seidlein HJ
    Pharm Prax; 1970; 11():241-7. PubMed ID: 5494136
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2.
    Manasse HR
    Am J Hosp Pharm; 1989 Jun; 46(6):1141-52. PubMed ID: 2750765
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parallel import of drugs for better and for worse].
    Krabbe U
    Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
    [No Abstract]   [Full Text] [Related]  

  • 5. Are drug proprietary names necessary?
    D'Arcy PF; Hadden DR
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
    [No Abstract]   [Full Text] [Related]  

  • 6. Customary and usual brand names.
    Sperber E
    N Engl J Med; 1969 Feb; 280(8):450. PubMed ID: 5763098
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the function of pharmacy and on some problems of cooperation in the system of material economy of Health Department especially between pharmacy and drug industry].
    Dittes W
    Pharm Prax; 1969; 4():93-5. PubMed ID: 5792751
    [No Abstract]   [Full Text] [Related]  

  • 8. The interactions between the drug industry and the prescribers and their effects on the quality and quantity of drugs.
    Juma FD
    East Afr Med J; 1984 Nov; 61(11):793-6. PubMed ID: 6535700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prescription by INN (International Non-Proprietary Name)].
    Elsen C; Nève J; Schetgen M
    J Pharm Belg; 2005; 60(3):77-83. PubMed ID: 16252508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strategies for pharmaceutical research and development. II. Generic drugs].
    Kuchar M
    Ceska Slov Farm; 1996 Jul; 45(4):171-6. PubMed ID: 8925240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
    Persson U; Ramsberg J
    Lakartidningen; 2007 Oct 17-23; 104(42):3046-50. PubMed ID: 17985712
    [No Abstract]   [Full Text] [Related]  

  • 12. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The place of drugs in health economics].
    Sigvard J
    Therapie; 1977; 32(5):529-52. PubMed ID: 349766
    [No Abstract]   [Full Text] [Related]  

  • 14. Why use generic names?
    Palmer DD
    Hawaii Med J; 1968; 27(4):321-4. PubMed ID: 5644836
    [No Abstract]   [Full Text] [Related]  

  • 15. [The new drug law of the German Democratic Republic and its significance for the evaluation of drugs].
    Richter J
    Z Arztl Fortbild (Jena); 1965 Apr; 59(8):413-20. PubMed ID: 5887305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance, causes and prevention of drug residues. Comments on the paper with the same title by Taubert K in Z.ärztl. Fortbild.70, Vol. (1976),4,p 194-200].
    Heller H
    Z Arztl Fortbild (Jena); 1977 Jan; 71(1):28-30. PubMed ID: 855372
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 18. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Informal conversation with colleagues about drugs, prices, as well as common duties and obligations].
    Hankiss J
    Orv Hetil; 1993 Oct; 134(43):2397. PubMed ID: 8233458
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.